<DOC>
	<DOCNO>NCT00406289</DOCNO>
	<brief_summary>This study evaluate feasibility high prolong dose escalation concentrate intra-tumoral region FDG-avid two week radiotherapy .</brief_summary>
	<brief_title>Trial Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy ( BG-IMRT ) Patients With Head Neck Tumor</brief_title>
	<detailed_description />
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<criteria>Head neck tumor Aged &gt; 18 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>